Vireo Growth (VREOF) Liabilities and Shareholders Equity (2020 - 2026)

Vireo Growth's (VREOF) quarterly Liabilities and Shareholders Equity came in at $928.8 million in Q1 2026, up 235.25% year-on-year from $277.0 million in Q1 2025, and up 13.66% quarter-over-quarter from $817.2 million in Q4 2025.

Vireo Growth (VREOF) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Vireo Growth has disclosed Liabilities and Shareholders Equity across 7 years of filings, most recently posting $928.8 million for Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $928.8 million, up 235.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 billion (up 226.56% YoY), and the FY2025 annual result was $817.2 million, up 193.05% from the prior year.
  • Liabilities and Shareholders Equity came in at $928.8 million for Q1 2026 at Vireo Growth, up from $817.2 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $928.8 million in Q1 2026 to a low of $158.6 million in Q1 2023.
  • The 5-year median for Liabilities and Shareholders Equity is $190.9 million (2024), against an average of $327.1 million.
  • Across the five-year window, Liabilities and Shareholders Equity dropped 4.68% in 2022 and jumped 250.19% in 2025, its largest moves.
  • Vireo Growth's Liabilities and Shareholders Equity stood at $159.2 million in 2022, then climbed by 15.15% to $183.3 million in 2023, then surged by 52.16% to $278.9 million in 2024, then soared by 193.05% to $817.2 million in 2025, then advanced by 13.66% to $928.8 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $928.8 million (Q1 2026), $817.2 million (Q4 2025), and $678.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.26 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.27 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.35 Bn
10 Vireo Growth - - 59.30 Mn 928.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 928.80 Mn
Dec 31, 2025 817.20 Mn
Sep 30, 2025 678.92 Mn
Jun 30, 2025 659.34 Mn
Mar 31, 2025 277.05 Mn
Dec 31, 2024 278.86 Mn
Sep 30, 2024 193.87 Mn
Jun 30, 2024 194.68 Mn
Mar 31, 2024 190.88 Mn
Dec 31, 2023 183.26 Mn
Sep 30, 2023 171.67 Mn
Jun 30, 2023 165.95 Mn
Mar 31, 2023 158.63 Mn
Dec 31, 2022 159.16 Mn
Sep 30, 2022 173.32 Mn
Jun 30, 2022 168.82 Mn
Mar 31, 2022 160.73 Mn
Dec 31, 2021 166.97 Mn
Sep 30, 2021 164.16 Mn
Jun 30, 2021 112.68 Mn